The European Union has announced today an additional €500 million for the COVAX Facility, doubling its contribution to date for the global initiative that is leading efforts to secure fair and equitable access to safe and effective COVID-19 vaccines in low and middle-income countries.
More
To exploit the full potential of contact tracing and warning apps to break the chain of coronavirus infections across borders and save lives, the Commission, at the invitation by EU Member States, has set up an EU-wide system to ensure interoperability – a so-called ‘gateway'.
More
Today, the European Commission approved a third contract with a pharmaceutical company, Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson.
More